TAG ARCHIVE

POSTS TAGGED AS oncology

Cancer Markers In Toenail Tissue

April 5, 2011 | Terry Sharrer | Posted in Newsletter

Nicotine accumulates in toenail tissue whether or not the toes belong to a smoker or a nonsmoker who had [MORE]

Internal Device for Navigating Cancer Treatments

March 22, 2011 | Terry Sharrer | Posted in Newsletter

By implanting a tracking sensor inside a surgical patient’s body, robotics manufacturer Adept Technology, Inc. (Pleasanton, CA) is testing [MORE]

Insight on DNA Repair

March 15, 2011 | Terry Sharrer | Posted in Newsletter

Near the end of chromosome 9′s long arm, the SET oncogene plays several roles in cellular function, including apoptosis, [MORE]

News and Views About Sleep

February 22, 2011 | Terry Sharrer | Posted in Newsletter

Sleep.com bills itself as “your online resource for sleep,” offering tips, products, and articles about this intriguing phenomena. While [MORE]

Microfluidics Chip for Cancer Diagnosis

February 15, 2011 | Terry Sharrer | Posted in Newsletter

Microfluidic chips that can capture cancer cells circulating in the blood have existed for a few years, but a [MORE]

Nanostructures for Drug Delivery

February 15, 2011 | Terry Sharrer | Posted in Newsletter

One of the great unknowns about cancer is how metastasized cells, sometimes, can develop drug resistance, making for a [MORE]

Oncotype DX Soaring

February 8, 2011 | Terry Sharrer | Posted in Newsletter

Oncotype DX is a “companion diagnostic” for women with early stage breast cancer who might be treated with hormone [MORE]

Growing Tumors Rapidly in the Lab

December 7, 2010 | Terry Sharrer | Posted in Newsletter

Todd Ridky, MD and a group at Stanford, were able to transform several human epithelial cells into invasive malignancies [MORE]

Promising Biomarker for Early Lung Cancer Detection

November 30, 2010 | Terry Sharrer | Posted in Newsletter

In the transition of loose connective tissue, known as mesenchyme, into epithelial cells of the lung, DNA methylation can silence [MORE]

Tracking Symptoms in Complex Disease

November 23, 2010 | Terry Sharrer | Posted in Newsletter

Cancer patients usually present multiple secondary symptoms, such as depression, fatigue, difficulty sleeping, joint and back pain, nausea and dry [MORE]

Chipping Away at Cancer

October 19, 2010 | Terry Sharrer | Posted in Newsletter

Microfluidic chips have been useful in capturing biomarkers and pathogens, but thus far they haven’t been particularly apt at [MORE]

Biorepository Collaboration

September 21, 2010 | Terry Sharrer | Posted in Newsletter

Earlier this year, Pfizer, Eli Lilly, and Merck agreed to create a nonprofit Asian Cancer Research Group to support [MORE]

Silica Nanoparticles as Delivery Vehicles for Anticancer Drugs

September 21, 2010 | Terry Sharrer | Posted in Newsletter

Imagine the sign on the door: “California NanoSystems Institute: Nano Machine Center for Targeted Delivery and On-Demand Release.”  [MORE]

Blood as a Source of iPSCs

August 2, 2010 | Terry Sharrer | Posted in Newsletter

Most of the R&D work on induced pluripotent stem cells has been done with skin tissue, but recently, investigators at [MORE]

3D Skin Monitoring to Detect Melanoma

June 22, 2010 | Terry Sharrer | Posted in Newsletter

Using a hand-held six light device, researchers at the Machine Vision Laboratory (Bristol Institute of Technology, Bristol, UK) are [MORE]

A Really Smart Biosensor Chip

May 25, 2010 | Terry Sharrer | Posted in Newsletter

Protein scientists in Germany and Japan have developed a new biochip that can detect proteins for specific diseases and [MORE]

Partners for Digital Pathology

May 4, 2010 | Terry Sharrer | Posted in Newsletter

Dr. Gerd Binning

Royal Philips Electonics, in the Netherlands, and Munich-based Definiens have signed an agreement to pursue molecular imaging.  [MORE]

Mapping Cancer on Chromosomes

March 30, 2010 | Terry Sharrer | Posted in Newsletter

A recent study reported on the importance of DNA copy number variations-both duplications and deletions on chromosomes-in causing cancers.  Indeed, [MORE]

Business in Companion Diagnostics

March 23, 2010 | Terry Sharrer | Posted in Newsletter

As an indication of things to come, Qiagen (Venlo, The Netherlands) signed an exclusive agreement with Johns Hopkins [MORE]

Tracking Personalized Biomarkers

March 16, 2010 | Terry Sharrer | Posted in Newsletter

Residual cancer, after surgery, leaves biomakers in the blood-both protein and DNA.  Protein markers tend to be less specific [MORE]